logo
  

Intercept Pharmaceuticals Inc. (ICPT) Is Down After Offering Announcement

Intercept Pharmaceuticals Inc. (ICPT) announced Tuesday morning that it has priced an underwritten public offering of 1,200,000 shares of its common stock.

Intercept Pharmaceuticals has gapped open sharply lower this morning and is now down 12.05 at $283.86. The stock is trading near the middle of over a 3-week range.

For comments and feedback contact: editorial@rttnews.com

Business News

Get Access to Premium Stock Alerts with RTT Biotech Investor.

First quarter growth data from China gained the maximum focus this week as trends in the massive emerging economy impact its trading partners. Elsewhere, the IMF released its latest global macroeconomic projections. Read our story to find out why comments from the Fed Chair Powell damped rate cut expectations. Meanwhile, there was some survey data that kindled hopes of a recovery in manufacturing. In the U.K., inflation data for March revealed some confusing trends.

View More Videos
Follow RTT